Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04541225
Recruitment Status : Recruiting
First Posted : September 9, 2020
Last Update Posted : July 20, 2021
Sponsor:
Information provided by (Responsible Party):
Nuvation Bio Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : December 2023